For patients at JosephCareRX who struggle with achieving adequate glycemic control through other treatments, Tirzepatide offers a promising alternative with its dual action on GIP and GLP-1 receptors, potentially providing enhanced benefits
Vendor and marketplace quality vary widely, so look for product-specific documentation
Important safety information Contraindications Hypersensitivity: to mecasermin (rhIGF-1), any of the inactive ingredients in INCRELEX, or who have experienced a severe hypersensitivity to INCRELEX
Variations in compounding practices can lead to impurities, incorrect dosages, and unexpected side effects
[PubMed: 12107213] 237
Some doctors may be aware of local resources, charitable programs, or clinical trials that could provide access to medication, though these are rare for weight loss medications specifically